Comparison of Immunological Abnormalities of Lymphocytes in Bone Marrow in Myelodysplastic Syndrome (MDS) and Aplastic Anemia (AA)

被引:19
|
作者
Li, Xiao [1 ]
Xu, Feng [1 ]
He, Qi [1 ]
Wu, Lingyun [1 ]
Zhang, Zheng [1 ]
Chang, Chunkang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Hosp 6, Dept Hematol, Shanghai, Peoples R China
关键词
myelodysplastic syndromes; aplastic anemia; lymphocytes; T cell subsets; polarization; ANTITHYMOCYTE GLOBULIN; T-CELLS; PATHOPHYSIOLOGY; HEMATOPOIESIS; REPERTOIRE; MANAGEMENT;
D O I
10.2169/internalmedicine.49.3477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The subsets and the polarization of lymphocytes in bone marrow from low-risk myelodysplastic syndrome (MDS) were studied and compared with those from patients with aplastic anemia (AA). Methods A total of 34 patients with low-risk MDS (IPSS score <= 1.0) who presented abnormal chromosomes and 16 patients with AA were enrolled in this study. We determined T lymphocyte subsets, T cells polarization status, and the percentages of NK cells and of B lymphocytes in bone marrow and compared these parameters between the two groups of patients. As controls, 24 patients with high-risk MDS (IPSS score>1.0) presenting abnormal chromosomes and 22 healthy/benign hematologic disease subjects were used. Results In low-risk MDS/AA patients, the percentage of CD3+ lymphocytes was significantly increased compared to controls (p=0.006 and p=0.001), while the percentage of CD19+ lymphocytes was significantly decreased (p<0.001 and p=0.002); there were no significant differences between MDS/AA and normal controls in other parameters; For low-risk MDS patients, the polarization status of bone marrow CD4+ cells toward Th1 (Th1/Th2) and of CD8+ cells toward Tc1 (Tc1/Tc2) was stronger than that for AA patients (p=0.05 and p<0.001). Other parameters did not show significant differences; Regardless of the predominance of CD4 or CD8 T cells, all patients with low-risk MDS were accompanied with elevated Tc1 polarization (Tc1/Tc2). Conclusion In both AA and MDS, the number of total T lymphocytes increased. However, polarization towards Th1 and Tc1 was obviously stronger in MDS patients than in AA patients. This might be related to T cell stimulation from the clones of malignant hematopoietic cells.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 50 条
  • [31] IMMUNOLOGICAL ABNORMALITIES IN CHILDREN WITH APLASTIC-ANEMIA
    WANG, WC
    HERROD, H
    PRESBURY, G
    CLINICAL RESEARCH, 1984, 32 (05): : A890 - A890
  • [32] The ratio of bone marrow myeloid progenitor cell proportion to mature lymphocytes proportion can effectively differentiate aplastic anemia and hypoplastic myelodysplastic syndrome and evaluate the quality of bone marrow aspirates
    Li, Zhen
    Zhang, Jian
    Han, Jingying
    Wang, Qian
    Sun, Hui
    Zhang, Zhifen
    Liu, Tianpu
    Che, Yena
    Wang, Jing
    Wang, Jie
    Xu, Lulu
    Pan, Lu
    Li, Li
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (06) : 1077 - 1083
  • [33] IMMUNOLOGICAL ABNORMALITIES IN MYELODYSPLASTIC SYNDROME
    SEITANIDES, B
    ANTONOPOULOU, A
    KARABELIS, A
    JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (08) : 922 - 923
  • [34] Characteristics of glycosylphosphatidylinositol (GPI)-anchored protein-deficient granulocytes and monocytes from patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS)
    Noji, H
    Okamoto, M
    Andoh, S
    Ikeda, K
    Nakamura, A
    Maruyama, Y
    Shichishima, T
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 66 - 66
  • [35] Frequent transformation to overt myelodysplastic syndromes (MDS) in the patients with aplastic anemia (AA) showing hematopoietic monoclonality at the AA onset.
    Kuriya, S
    Chiba, H
    Goishi, S
    Ishida, Y
    BLOOD, 1999, 94 (10) : 410A - 411A
  • [36] PROGNOSIS OF APLASTIC-ANEMIA (AA) AND INDICATION FOR BONE-MARROW TRANSPLANTATION
    HAAK, HL
    TEVELDE, J
    HERMANS, J
    REMME, J
    EXPERIMENTAL HEMATOLOGY, 1977, 5 : 102 - 102
  • [37] PROGNOSIS OF APLASTIC-ANEMIA (AA) AND INDICATION FOR BONE-MARROW TRANSPLANTATION
    HAAK, HL
    TEVELDE, J
    HERMANS, J
    REMME, J
    ZWAAN, FE
    GUIOT, HFL
    MEER, CWVD
    HARTGRINKGROENEVELD, CA
    EERNISSE, JG
    BRAND, A
    VANROOD, JJ
    PATHOLOGIE BIOLOGIE, 1978, 26 (01): : 33 - 34
  • [38] Expression of CXCL12 in Bone Marrow Is Different Between Myelodysplastic Syndrome and Aplastic Anemia by Immunohistochemical Stain
    Chang, Chen
    Chen, Hui-Wen
    Chiang, Jung-Ting
    MODERN PATHOLOGY, 2018, 31 : 504 - 505
  • [39] Expression of CXCL12 in Bone Marrow Is Different Between Myelodysplastic Syndrome and Aplastic Anemia by Immunohistochemical Stain
    Chang, Chen
    Chen, Hui-Wen
    Chiang, Jung-Ting
    LABORATORY INVESTIGATION, 2018, 98 : 504 - 505
  • [40] LYMPHOCYTE-T AND LYMPHOCYTE-B IN THE BONE-MARROW OF APLASTIC-ANEMIA AND MYELODYSPLASTIC SYNDROME
    OHSHIMA, K
    MASUDA, Y
    YOSHIDA, T
    KIKUCHI, M
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (07): : 1196 - 1201